Cytodyn Inc (CYDY)

[ClosetInvestor]

“Approval would have likely been this week had they simply recommended they change the primary endpoint to what everyone else was doing, but the DSMC made a huge blunder that could ultimately cost tens of thousands of American lives.”

Is this article a joke? The DSMC did not instruct CYDY to finish the trial, they told NP at 50% to conduct another analysis at 75%. This “article” appears to be written by an investor who doesn’t understand the clinical trial process. The blame for the failure of CD12 is on the Shoulders of NP, not the DSMC.